Oral Cholera Vaccine Market Report

Global Oral Cholera Vaccine Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • POSTDATE：Jun 08, 2022
  • PAGES：150
  • REPORT CODE：GMM848379
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Oral Cholera Vaccine market report explains the definition, types, applications, major countries, and major players of the Oral Cholera Vaccine market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Sanofi

    • EuBiologics

    • PaxVax

    • Valneva

    By Type:

    • Shanchol

    • Dukoral

    • Vaxchora

    • Others

    By End-User:

    • Hospital

    • Research & Academic Laboratories

    • Pharmaceutical & Biotechnology Companies

    • Others

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Oral Cholera Vaccine Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Oral Cholera Vaccine Outlook to 2028- Original Forecasts

    • 2.2 Oral Cholera Vaccine Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Oral Cholera Vaccine Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Oral Cholera Vaccine Market- Recent Developments

    • 6.1 Oral Cholera Vaccine Market News and Developments

    • 6.2 Oral Cholera Vaccine Market Deals Landscape

    7 Oral Cholera Vaccine Raw Materials and Cost Structure Analysis

    • 7.1 Oral Cholera Vaccine Key Raw Materials

    • 7.2 Oral Cholera Vaccine Price Trend of Key Raw Materials

    • 7.3 Oral Cholera Vaccine Key Suppliers of Raw Materials

    • 7.4 Oral Cholera Vaccine Market Concentration Rate of Raw Materials

    • 7.5 Oral Cholera Vaccine Cost Structure Analysis

      • 7.5.1 Oral Cholera Vaccine Raw Materials Analysis

      • 7.5.2 Oral Cholera Vaccine Labor Cost Analysis

      • 7.5.3 Oral Cholera Vaccine Manufacturing Expenses Analysis

    8 Global Oral Cholera Vaccine Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Oral Cholera Vaccine Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Oral Cholera Vaccine Export by Region (Top 10 Countries) (2017-2028)

    9 Global Oral Cholera Vaccine Market Outlook by Types and Applications to 2022

    • 9.1 Global Oral Cholera Vaccine Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Shanchol Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Dukoral Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Vaxchora Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Oral Cholera Vaccine Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Research & Academic Laboratories Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Pharmaceutical & Biotechnology Companies Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Others Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Oral Cholera Vaccine Market Analysis and Outlook till 2022

    • 10.1 Global Oral Cholera Vaccine Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Oral Cholera Vaccine Consumption (2017-2022)

      • 10.2.2 Canada Oral Cholera Vaccine Consumption (2017-2022)

      • 10.2.3 Mexico Oral Cholera Vaccine Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Oral Cholera Vaccine Consumption (2017-2022)

      • 10.3.2 UK Oral Cholera Vaccine Consumption (2017-2022)

      • 10.3.3 Spain Oral Cholera Vaccine Consumption (2017-2022)

      • 10.3.4 Belgium Oral Cholera Vaccine Consumption (2017-2022)

      • 10.3.5 France Oral Cholera Vaccine Consumption (2017-2022)

      • 10.3.6 Italy Oral Cholera Vaccine Consumption (2017-2022)

      • 10.3.7 Denmark Oral Cholera Vaccine Consumption (2017-2022)

      • 10.3.8 Finland Oral Cholera Vaccine Consumption (2017-2022)

      • 10.3.9 Norway Oral Cholera Vaccine Consumption (2017-2022)

      • 10.3.10 Sweden Oral Cholera Vaccine Consumption (2017-2022)

      • 10.3.11 Poland Oral Cholera Vaccine Consumption (2017-2022)

      • 10.3.12 Russia Oral Cholera Vaccine Consumption (2017-2022)

      • 10.3.13 Turkey Oral Cholera Vaccine Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Oral Cholera Vaccine Consumption (2017-2022)

      • 10.4.2 Japan Oral Cholera Vaccine Consumption (2017-2022)

      • 10.4.3 India Oral Cholera Vaccine Consumption (2017-2022)

      • 10.4.4 South Korea Oral Cholera Vaccine Consumption (2017-2022)

      • 10.4.5 Pakistan Oral Cholera Vaccine Consumption (2017-2022)

      • 10.4.6 Bangladesh Oral Cholera Vaccine Consumption (2017-2022)

      • 10.4.7 Indonesia Oral Cholera Vaccine Consumption (2017-2022)

      • 10.4.8 Thailand Oral Cholera Vaccine Consumption (2017-2022)

      • 10.4.9 Singapore Oral Cholera Vaccine Consumption (2017-2022)

      • 10.4.10 Malaysia Oral Cholera Vaccine Consumption (2017-2022)

      • 10.4.11 Philippines Oral Cholera Vaccine Consumption (2017-2022)

      • 10.4.12 Vietnam Oral Cholera Vaccine Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Oral Cholera Vaccine Consumption (2017-2022)

      • 10.5.2 Colombia Oral Cholera Vaccine Consumption (2017-2022)

      • 10.5.3 Chile Oral Cholera Vaccine Consumption (2017-2022)

      • 10.5.4 Argentina Oral Cholera Vaccine Consumption (2017-2022)

      • 10.5.5 Venezuela Oral Cholera Vaccine Consumption (2017-2022)

      • 10.5.6 Peru Oral Cholera Vaccine Consumption (2017-2022)

      • 10.5.7 Puerto Rico Oral Cholera Vaccine Consumption (2017-2022)

      • 10.5.8 Ecuador Oral Cholera Vaccine Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Oral Cholera Vaccine Consumption (2017-2022)

      • 10.6.2 Kuwait Oral Cholera Vaccine Consumption (2017-2022)

      • 10.6.3 Oman Oral Cholera Vaccine Consumption (2017-2022)

      • 10.6.4 Qatar Oral Cholera Vaccine Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Oral Cholera Vaccine Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Oral Cholera Vaccine Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Oral Cholera Vaccine Consumption (2017-2022)

      • 10.7.2 South Africa Oral Cholera Vaccine Consumption (2017-2022)

      • 10.7.3 Egypt Oral Cholera Vaccine Consumption (2017-2022)

      • 10.7.4 Algeria Oral Cholera Vaccine Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Oral Cholera Vaccine Consumption (2017-2022)

      • 10.8.2 New Zealand Oral Cholera Vaccine Consumption (2017-2022)

    11 Global Oral Cholera Vaccine Competitive Analysis

    • 11.1 Sanofi

      • 11.1.1 Sanofi Company Details

      • 11.1.2 Sanofi Oral Cholera Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Sanofi Oral Cholera Vaccine Main Business and Markets Served

      • 11.1.4 Sanofi Oral Cholera Vaccine Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 EuBiologics

      • 11.2.1 EuBiologics Company Details

      • 11.2.2 EuBiologics Oral Cholera Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 EuBiologics Oral Cholera Vaccine Main Business and Markets Served

      • 11.2.4 EuBiologics Oral Cholera Vaccine Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 PaxVax

      • 11.3.1 PaxVax Company Details

      • 11.3.2 PaxVax Oral Cholera Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 PaxVax Oral Cholera Vaccine Main Business and Markets Served

      • 11.3.4 PaxVax Oral Cholera Vaccine Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Valneva

      • 11.4.1 Valneva Company Details

      • 11.4.2 Valneva Oral Cholera Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Valneva Oral Cholera Vaccine Main Business and Markets Served

      • 11.4.4 Valneva Oral Cholera Vaccine Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    12 Global Oral Cholera Vaccine Market Outlook by Types and Applications to 2028

    • 12.1 Global Oral Cholera Vaccine Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Shanchol Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Dukoral Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.3 Global Vaxchora Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.4 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Oral Cholera Vaccine Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Research & Academic Laboratories Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Pharmaceutical & Biotechnology Companies Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Oral Cholera Vaccine Market Analysis and Outlook to 2028

    • 13.1 Global Oral Cholera Vaccine Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Oral Cholera Vaccine Consumption Forecast (2022-2028)

      • 13.2.2 Canada Oral Cholera Vaccine Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Oral Cholera Vaccine Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Oral Cholera Vaccine Consumption Forecast (2022-2028)

      • 13.3.2 UK Oral Cholera Vaccine Consumption Forecast (2022-2028)

      • 13.3.3 Spain Oral Cholera Vaccine Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Oral Cholera Vaccine Consumption Forecast (2022-2028)

      • 13.3.5 France Oral Cholera Vaccine Consumption Forecast (2022-2028)

      • 13.3.6 Italy Oral Cholera Vaccine Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Oral Cholera Vaccine Consumption Forecast (2022-2028)

      • 13.3.8 Finland Oral Cholera Vaccine Consumption Forecast (2022-2028)

      • 13.3.9 Norway Oral Cholera Vaccine Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Oral Cholera Vaccine Consumption Forecast (2022-2028)

      • 13.3.11 Poland Oral Cholera Vaccine Consumption Forecast (2022-2028)

      • 13.3.12 Russia Oral Cholera Vaccine Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Oral Cholera Vaccine Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Oral Cholera Vaccine Consumption Forecast (2022-2028)

      • 13.4.2 Japan Oral Cholera Vaccine Consumption Forecast (2022-2028)

      • 13.4.3 India Oral Cholera Vaccine Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Oral Cholera Vaccine Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Oral Cholera Vaccine Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Oral Cholera Vaccine Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Oral Cholera Vaccine Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Oral Cholera Vaccine Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Oral Cholera Vaccine Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Oral Cholera Vaccine Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Oral Cholera Vaccine Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Oral Cholera Vaccine Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Oral Cholera Vaccine Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Oral Cholera Vaccine Consumption Forecast (2022-2028)

      • 13.5.3 Chile Oral Cholera Vaccine Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Oral Cholera Vaccine Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Oral Cholera Vaccine Consumption Forecast (2022-2028)

      • 13.5.6 Peru Oral Cholera Vaccine Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Oral Cholera Vaccine Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Oral Cholera Vaccine Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Oral Cholera Vaccine Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Oral Cholera Vaccine Consumption Forecast (2022-2028)

      • 13.6.3 Oman Oral Cholera Vaccine Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Oral Cholera Vaccine Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Oral Cholera Vaccine Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Oral Cholera Vaccine Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Oral Cholera Vaccine Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Oral Cholera Vaccine Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Oral Cholera Vaccine Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Oral Cholera Vaccine Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Oral Cholera Vaccine Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Oral Cholera Vaccine Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Oral Cholera Vaccine

    • Figure of Oral Cholera Vaccine Picture

    • Table Global Oral Cholera Vaccine Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Oral Cholera Vaccine Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Shanchol Consumption and Growth Rate (2017-2022)

    • Figure Global Dukoral Consumption and Growth Rate (2017-2022)

    • Figure Global Vaxchora Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Consumption and Growth Rate (2017-2022)

    • Figure Global Research & Academic Laboratories Consumption and Growth Rate (2017-2022)

    • Figure Global Pharmaceutical & Biotechnology Companies Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Oral Cholera Vaccine Consumption by Country (2017-2022)

    • Table North America Oral Cholera Vaccine Consumption by Country (2017-2022)

    • Figure United States Oral Cholera Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Canada Oral Cholera Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Mexico Oral Cholera Vaccine Consumption and Growth Rate (2017-2022)

    • Table Europe Oral Cholera Vaccine Consumption by Country (2017-2022)

    • Figure Germany Oral Cholera Vaccine Consumption and Growth Rate (2017-2022)

    • Figure UK Oral Cholera Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Spain Oral Cholera Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Belgium Oral Cholera Vaccine Consumption and Growth Rate (2017-2022)

    • Figure France Oral Cholera Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Italy Oral Cholera Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Denmark Oral Cholera Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Finland Oral Cholera Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Norway Oral Cholera Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Sweden Oral Cholera Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Poland Oral Cholera Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Russia Oral Cholera Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Turkey Oral Cholera Vaccine Consumption and Growth Rate (2017-2022)

    • Table APAC Oral Cholera Vaccine Consumption by Country (2017-2022)

    • Figure China Oral Cholera Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Japan Oral Cholera Vaccine Consumption and Growth Rate (2017-2022)

    • Figure India Oral Cholera Vaccine Consumption and Growth Rate (2017-2022)

    • Figure South Korea Oral Cholera Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Oral Cholera Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Oral Cholera Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Oral Cholera Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Thailand Oral Cholera Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Singapore Oral Cholera Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Oral Cholera Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Philippines Oral Cholera Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Oral Cholera Vaccine Consumption and Growth Rate (2017-2022)

    • Table South America Oral Cholera Vaccine Consumption by Country (2017-2022)

    • Figure Brazil Oral Cholera Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Colombia Oral Cholera Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Chile Oral Cholera Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Argentina Oral Cholera Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Oral Cholera Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Peru Oral Cholera Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Oral Cholera Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Oral Cholera Vaccine Consumption and Growth Rate (2017-2022)

    • Table GCC Oral Cholera Vaccine Consumption by Country (2017-2022)

    • Figure Bahrain Oral Cholera Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Oral Cholera Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Oman Oral Cholera Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Qatar Oral Cholera Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Oral Cholera Vaccine Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Oral Cholera Vaccine Consumption and Growth Rate (2017-2022)

    • Table Africa Oral Cholera Vaccine Consumption by Country (2017-2022)

    • Figure Nigeria Oral Cholera Vaccine Consumption and Growth Rate (2017-2022)

    • Figure South Africa Oral Cholera Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Egypt Oral Cholera Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Algeria Oral Cholera Vaccine Consumption and Growth Rate (2017-2022)

    • Table Oceania Oral Cholera Vaccine Consumption by Country (2017-2022)

    • Figure Australia Oral Cholera Vaccine Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Oral Cholera Vaccine Consumption and Growth Rate (2017-2022)

    • Table Sanofi Company Details

    • Table Sanofi Oral Cholera Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Oral Cholera Vaccine Main Business and Markets Served

    • Table Sanofi Oral Cholera Vaccine Product Portfolio

    • Table EuBiologics Company Details

    • Table EuBiologics Oral Cholera Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table EuBiologics Oral Cholera Vaccine Main Business and Markets Served

    • Table EuBiologics Oral Cholera Vaccine Product Portfolio

    • Table PaxVax Company Details

    • Table PaxVax Oral Cholera Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table PaxVax Oral Cholera Vaccine Main Business and Markets Served

    • Table PaxVax Oral Cholera Vaccine Product Portfolio

    • Table Valneva Company Details

    • Table Valneva Oral Cholera Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Valneva Oral Cholera Vaccine Main Business and Markets Served

    • Table Valneva Oral Cholera Vaccine Product Portfolio

    • Figure Global Shanchol Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Dukoral Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Vaxchora Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Research & Academic Laboratories Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Pharmaceutical & Biotechnology Companies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Oral Cholera Vaccine Consumption Forecast by Country (2022-2028)

    • Table North America Oral Cholera Vaccine Consumption Forecast by Country (2022-2028)

    • Figure United States Oral Cholera Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Oral Cholera Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Oral Cholera Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Oral Cholera Vaccine Consumption Forecast by Country (2022-2028)

    • Figure Germany Oral Cholera Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Oral Cholera Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Oral Cholera Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Oral Cholera Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Oral Cholera Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Oral Cholera Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Oral Cholera Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Oral Cholera Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Oral Cholera Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Oral Cholera Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Oral Cholera Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Oral Cholera Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Oral Cholera Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Oral Cholera Vaccine Consumption Forecast by Country (2022-2028)

    • Figure China Oral Cholera Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Oral Cholera Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Oral Cholera Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Oral Cholera Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Oral Cholera Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Oral Cholera Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Oral Cholera Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Oral Cholera Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Oral Cholera Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Oral Cholera Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Oral Cholera Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Oral Cholera Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Oral Cholera Vaccine Consumption Forecast by Country (2022-2028)

    • Figure Brazil Oral Cholera Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Oral Cholera Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Oral Cholera Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Oral Cholera Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Oral Cholera Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Oral Cholera Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Oral Cholera Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Oral Cholera Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Oral Cholera Vaccine Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Oral Cholera Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Oral Cholera Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Oral Cholera Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Oral Cholera Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Oral Cholera Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Oral Cholera Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Oral Cholera Vaccine Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Oral Cholera Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Oral Cholera Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Oral Cholera Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Oral Cholera Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Oral Cholera Vaccine Consumption Forecast by Country (2022-2028)

    • Figure Australia Oral Cholera Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Oral Cholera Vaccine Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US